Cited by 147Gastrointestinal motility and disordersNeuropeptides and Animal PhysiologyStress Responses and Cortisol

Brain and gut CRF signaling: biological actions and role in the gastrointestinal tract

Open access
Tache, Yvette, Larauche, Muriel, Yuan, Pu-Qing, Million, Mulugeta·2018·Current Molecular Pharmacology

Abstract

Background Corticotropin-releasing factor (CRF) pathways coordinate behavioral, endocrine, autonomic and visceral responses to stress. Convergent anatomical, molecular, pharmacological and functional experimental evidence supports a key role of brain CRF receptor (CRF-R) signaling in stress-related alterations of gastrointestinal functions. These include the inhibition of gastric acid secretion and gastric-small intestinal transit, stimulation of colonic enteric nervous system and secretorymotor function, increase intestinal permeability, and visceral hypersensitivity. Brain sites of CRF actions to alter gut motility encompass the paraventricular nucleus of the hypothalamus, locus coeruleus complex and the dorsal motor nucleus while those modulating visceral pain are localized in the hippocampus and central amygdala. Brain CRF actions are mediated through the autonomic nervous system (decreased gastric vagal and increased sacral parasympathetic and sympathetic activities). The activation of brain CRF-R2 subtype inhibits gastric motor function while CRF-R1 stimulates colonic secretomotor function and induces visceral hypersensitivity. CRF signaling is also located within the gut where CRF-R1 activates colonic myenteric neurons, mucosal cells secreting serotonin, mucus, prostaglandin E2, induces mast cell degranulation, enhances mucosal permeability and propulsive motor functions and induces visceral hyperalgesia in animals and humans. CRF-R1 antagonists prevent CRF- and stressrelated gut alterations in rodents while not influencing basal state. Discussion These preclinical studies contrast with the limited clinical positive outcome of CRF-R1 antagonists to alleviate stress-sensitive functional bowel diseases such as irritable bowel syndrome. Conclusion The translational potential of CRF-R1 antagonists in gut diseases will require additional studies directed to novel anti-CRF therapies and the neurobiology of brain-gut interactions under chronic stress.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1874467210666170224095741

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CRF acts on enteric peristalsis, secretion, and the mucosal barrier, playing a role in functional and organic disorders, such as IBS and IBD.

    “CRF acts on enteric peristalsis, secretion, and the mucosal barrier, playing a role in functional and organic disorders, such as IBS and IBD (23).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 9 · Cited by 147

Research works printed but not linked: 14

  1. [36]Taché Y; Brunnhuber S From Hans Selye’s discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases. Ann. N. Y. Acad. Sci, 2008, 1148, 29– 41. 19120089 PMC2993154
  2. [51]Gunion MW; Kauffman GL; Taché Y Intrahypothalamic microinfusion of corticotropin-releasing factor elevates gastric bicarbonate secretion and protects against cold-stress ulceration in rats. Am. J. Physiol, 1990, 258, G152– G157. 2301576
  3. [56]Lenz HJ; Klapdor R; Hester SE; Webb VJ; Galyean RF; Rivier JE; Brown MR Inhibition of gastric acid secretion by brain peptides in the dog. Role of the autonomic nervous system and gastrin. Gastroenterology, 1986, 91, 905– 912. 2943629
  4. [57]Beaumont W In Experiments and Observations on the Gastric Juice and the Physiology of Digestion, Osler W, Ed.; Dover Publications Inc.: New York, 1833, pp. 1– 280.
  5. [58]Cannon WB Bodily changes in pain, hunger, fear and rage; Branford, CT: Boston, 1953. pp. 1– 404.
  6. [88]Taché Y; Barquist E; Stephens RL; Rivier J Abdominal surgery- and trephination-induced delay in gastric emptying is prevented by intracisternal injection of CRF antagonist in the rat. J. Gastrointest. Motil, 1991, 3, 19– 25.
  7. [96]Swanson LW; Sawchenko PE Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology, 1980, 31, 410– 417. 6109264
  8. [101]Suto G; Kiraly A; Plourde V; Taché Y Intravenous interleukin-1-beta-induced inhibition of gastric emptying: involvement of central corticotropin-releasing factor and prostaglandin pathways in rats. Digestion, 1996, 57, 135– 140. 8786002
  9. [102]Taché Y; Martinez V; Million M; Wang L Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am. J. Physiol, 2001, 280, G173– G177. 11208537
  10. [113]Smedh U; Moran TH Peptides that regulate food intake: separable mechanisms for dorsal hindbrain CART peptide to inhibit gastric emptying and food intake. Am. J. Physiol, 2003, 284, R1418– R1426. 12468444
  11. [119]Lenz HJ; Forquignon I; Druge G; Friemel E; Rivier JE; Raedler A; Greten H Central nervous system effects of hypothalamic peptides on gastric acid and proximal duodenal bicarbonate secretions in rats. Gastroenterology, 1987, 92, 1501 Abstr.
  12. [209]Kravets JL; Reyes BA; Unterwald EM; Van Bockstaele EJ Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitry. Brain Struct. Funct, 2015, 220(1), 541– 58. 24271021 PMC4032379
  13. [270]Kawahito Y; Sano H; Chrousos GP; Wilder RL; Yuri K; Katawa M; Kato H; Kondo M The production of corticotropin-releasing hormone in normal human colonic mucosal cells (enterochromaffin cells). Gastroenterology, 1993, 104, A1044. 7511553
  14. [277]Kern W; Schiefer B; Schwarzenburg J; Stange EF; Born J; Fehm HL Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans. Neuroendocrinology, 1997, 65, 291– 298. 9143001

Authors
Tache, Y., Larauche, M., Yuan, P.-Q., & Million, M.
Affiliations
  • CURE/Digestive Diseases Research Center, G Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Digestive Diseases Division, David Geffen School of Medicine at UCLA and VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, United States
  • University of California, Los Angeles (US)
Venue
Current Molecular Pharmacology
Publisher
Elsevier BV
Published
2018-01-03
Volume
11
Issue
1
Pages
51-71
ISSN
1874-4672 (ISSN-L)
OpenAlex
W2594882031
Cited by
147
References
9
Citations by year
2026: 12 · 2025: 19 · 2024: 14 · 2023: 19 · 2022: 25 · 2021: 18 · 2020: 16 · 2019: 10 · 2018: 9 · 2017: 5
FWCI
11.49
Type
journal article
Language
en
Open access
Locations
  • Current Molecular Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (P50DK064539, R01DK078676, P30DK041301, K01DK088937, R01DK057236)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
corticotropin-releasing factor, CRF1 receptor, CRF receptor 2, gut-brain axis, stress, gastrointestinal motility, gastric acid secretion, visceral hypersensitivity, intestinal permeability, enteric nervous system, paraventricular nucleus, locus coeruleus, dorsal motor nucleus of the vagus, hippocampus, central amygdala, autonomic nervous system, mast cell degranulation, serotonin, prostaglandin E2, irritable bowel syndrome, functional bowel disorders, chronic stress
MeSH terms
Animals, Brain, Corticotropin-Releasing Hormone, Humans, Motor Activity, Signal Transduction, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review